TAOK2 Recombinant antibody

TAOK2 Uni-rAbTM Recombinant Antibody for WB, ELISA
Cat No. 86221-1-RR

产品说明书

CloneNo. 250450B1

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

WB, ELISA

EC:2.7.11.1, hKFC-C, KIAA0881, MAP3K17, Prostate-derived STE20-like kinase 1

缓冲液配方:  PBS and Azide
PBS and Azide
PBS Only
偶联物:  Unconjugated
Unconjugated
规格价格库存


经过测试的应用

Positive WB detected inHeLa cells, Hep cells, HEK-293 cells

推荐稀释比

应用推荐稀释比
Western Blot (WB)WB : 1:1000-1:4000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

86221-1-RR targets TAOK2 in WB, ELISA applications and shows reactivity with human samples.

经测试应用 WB, ELISA Application Description
经测试反应性 human
免疫原 TAOK2 fusion protein Ag15521 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Recombinant
产品类型 Antibody
全称 TAO kinase 2
别名 EC:2.7.11.1, hKFC-C, KIAA0881, MAP3K17, Prostate-derived STE20-like kinase 1
计算分子量 1235 aa, 138 kDa
观测分子量 138-150 kDa
GenBank蛋白编号BC142663
基因名称 TAOK2
Gene ID (NCBI) 9344
偶联类型 Unconjugated
形式 Liquid
纯化方式Protein A purification
UNIPROT IDQ9UL54
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

TAOK2(Serine/threonine-protein kinase TAO2) is also named as KIAA0881, MAP3K17, PSK, PSK1 and belongs to the protein kinase superfamily. TAOK2 is known to modulate gene transcription via its activation of several MAP kinase pathways, including c-Jun amino-terminal kinase (JNK), and has been implicated in the modulation of actin and microtubule dynamics. The time course of TAOK2 expression is consistent with a role for it in neuronal differentiation.(PMID:22735514). The immunogen of this antibody is 742-969 aa of human TAOK2 protein isoform Alpha.This antibody mainly detects the isoform 1/3/4. It can't detect the isoform 2.

实验方案

Product Specific Protocols
WB protocol for TAOK2 antibody 86221-1-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...